Line 13: |
Line 13: |
| <td style='width:25%'>TBS;SSC</td> | | <td style='width:25%'>TBS;SSC</td> |
| <td style='width:25%'>Information</td> | | <td style='width:25%'>Information</td> |
− | </tr>
| |
− | <tr>
| |
− | <td style='width:50%'>TC - Regulatory Evaluation Platform (REP)</td>
| |
− | <td style='width:25%'>TC</td>
| |
− | <td style='width:25%'>Endorsement</td>
| |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 76: |
Line 71: |
| <td style='width:50%'>ISED - Strategic Science Fund</td> | | <td style='width:50%'>ISED - Strategic Science Fund</td> |
| <td style='width:25%'>ISED</td> | | <td style='width:25%'>ISED</td> |
| + | <td style='width:25%'>Endorsement</td> |
| + | </tr> |
| + | <tr> |
| + | <td style='width:50%'>TC - Regulatory Evaluation Platform (REP)</td> |
| + | <td style='width:25%'>TC</td> |
| <td style='width:25%'>Endorsement</td> | | <td style='width:25%'>Endorsement</td> |
| </tr> | | </tr> |
Line 105: |
Line 105: |
| <td style='width:50%'>DFO - Enterprise Grants and Contributions (eGs&Cs)</td> | | <td style='width:50%'>DFO - Enterprise Grants and Contributions (eGs&Cs)</td> |
| <td style='width:25%'>DFO</td> | | <td style='width:25%'>DFO</td> |
| + | <td style='width:25%'>Endorsement</td> |
| + | </tr> |
| + | <tr> |
| + | <td style='width:50%'>ISC - Medical Transportation Claims Processing Services and Solution</td> |
| + | <td style='width:25%'>ISC</td> |
| <td style='width:25%'>Endorsement</td> | | <td style='width:25%'>Endorsement</td> |
| </tr> | | </tr> |
Line 357: |
Line 362: |
| <td style='width:25%'>TBS;SSC</td> | | <td style='width:25%'>TBS;SSC</td> |
| <td style='width:25%'>Information</td> | | <td style='width:25%'>Information</td> |
− | </tr>
| |
− | <tr>
| |
− | <td style='width:50%'>TC - Regulatory Evaluation Platform (REP)</td>
| |
− | <td style='width:25%'>TC</td>
| |
− | <td style='width:25%'>Approbation</td>
| |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 420: |
Line 420: |
| <td style='width:50%'>ISED - Strategic Science Fund</td> | | <td style='width:50%'>ISED - Strategic Science Fund</td> |
| <td style='width:25%'>ISED</td> | | <td style='width:25%'>ISED</td> |
| + | <td style='width:25%'>Approbation</td> |
| + | </tr> |
| + | <tr> |
| + | <td style='width:50%'>TC - Regulatory Evaluation Platform (REP)</td> |
| + | <td style='width:25%'>TC</td> |
| <td style='width:25%'>Approbation</td> | | <td style='width:25%'>Approbation</td> |
| </tr> | | </tr> |
Line 449: |
Line 454: |
| <td style='width:50%'>DFO - Enterprise Grants and Contributions (eGs&Cs)</td> | | <td style='width:50%'>DFO - Enterprise Grants and Contributions (eGs&Cs)</td> |
| <td style='width:25%'>DFO</td> | | <td style='width:25%'>DFO</td> |
| + | <td style='width:25%'>Approbation</td> |
| + | </tr> |
| + | <tr> |
| + | <td style='width:50%'>ISC - Medical Transportation Claims Processing Services and Solution</td> |
| + | <td style='width:25%'>ISC</td> |
| <td style='width:25%'>Approbation</td> | | <td style='width:25%'>Approbation</td> |
| </tr> | | </tr> |